GlassScriptPhysician profile
Amy J Mathers
NPI 1821025107
$21,385.09
in general payments reported to CMS, 2019-2025
8 companies · $53.00 in 2025
The $53.00 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,000 · 2020: $2,675 · 2021: $4,119 · 2022: $3,938 · 2023: $1,957 · 2024: $6,643 · 2025: $53.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,540 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,200 · Consulting Fee: $1,860 · Travel and Lodging: $903 · Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,540.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,200.00 |
| Consulting Fee | $1,860.00 |
| Travel and Lodging | $903.40 |
| Food and Beverage | $149.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $5,610.00 | 2020-2023 | |
| Biomerieux INC | $4,496.40 | 2024-2025 | |
| Cepheid | $2,500.00 | 2022 | |
| Beckman Coulter, INC. | $2,200.00 | 2024 | |
| Accelerate Diagnostics INC. | $2,093.75 | 2019-2021 | |
| Melinta Therapeutics, LLC | $1,925.00 | 2021 | |
| Life Technologies Corporation | $1,400.00 | 2022 | |
| Shionogi INC | $1,159.94 | 2020-2023 | Fetroja |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mathers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.